Clinical Trials Browser

Adenocarcinoma of the Stomach × toripalimab × Gastrointestinal × Clear all

NCT05715931 2024-09-19

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma of the Stomach

NCT05970627 2023-08-01

Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma of the Stomach